Index
-
Market Cap
4.57B
Enterprise Value
6.29B
Income
173.47M
Sales
1.23B
Book/sh
2.33
Cash/sh
1.45
Employees
3000
IPO
Nov 20, 2020
P/E
26.64
Forward P/E
14.97
PEG
1.36
P/S
3.72
P/B
6.87
P/C
11.09
P/FCF
34.18
EV/EBITDA
11.10
EV/Sales
5.11
Quick Ratio
2.91
Current Ratio
3.13
Debt/Eq
2.90
LT Debt/Eq
2.90
Option/Short
Yes / Yes
EPS (ttm)
0.60
EPS next Y
1.07
EPS next Q
0.27
EPS this Y
14.51%
EPS next Y
8.70%
EPS next 5Y
11.04%
EPS past 3/5Y
- -
Sales past 3/5Y
5.05% 7.30%
EPS Y/Y TTM
211.53%
Sales Y/Y TTM
6.90%
EPS Q/Q
19.61%
Sales Q/Q
4.36%
Insider Own
2.10%
Insider Trans
-89.71%
Inst Own
104.45%
Inst Trans
-4.33%
ROA
5.28%
ROE
27.03%
ROIC
6.07%
Gross Margin
53.64%
Oper. Margin
35.53%
Profit Margin
14.11%
SMA20
-10.84%
SMA50
-12.98%
SMA200
-5.59%
Trades
Shs Outstand
285.38M
Shs Float
279.37M
52W High
19.85 -19.24%
52W Low
13.09 22.46%
Volatility
3.12% 3.00%
ATR (14)
0.61
RSI (14)
27.07
Beta
1.93
Rel Volume
2.34
Avg Volume
2.29M
Volume
5,360,813
Perf Week
-13.30%
Perf Month
-13.58%
Perf Quarter
-10.85%
Perf Half Y
4.57%
Perf YTD
-9.13%
Perf Year
-3.49%
Perf 3Y
21.35%
Perf 5Y
-40.34%
Perf 10Y
-
Prev Close
17.74
Price
16.03
Change %
-9.64%
Analysts 11 incl. previous ratings
Rating Distribution 9 Buy · 1 Hold · 1 Sell
Date Action Analyst Rating Change Price Target Change Implied Upside Oct 14, 2026 Downgrade J JP Morgan
Neutral → Underweight $17 +6.1% Jun 05, 2026 Initiated G Goldman
Buy $20 +24.8% Jan 09, 2026 Upgrade P
Neutral → Overweight $24 +49.7% Jan 09, 2026 Resumed R RBC Capital Mkts
Outperform $24 +49.7% Dec 18, 2025 Initiated W
Outperform Nov 13, 2025 Initiated B BMO Capital Markets
Outperform $19 +18.5% May 05, 2025 Upgrade G Goldman
Neutral → Buy $17 +6.1% Dec 06, 2024 Initiated G Goldman
Neutral $14 -12.7% May 21, 2024 Initiated P
Neutral $13 -18.9% Apr 03, 2024 Upgrade C Citigroup
Neutral → Buy $18 → $16 -0.2% Mar 25, 2024 Upgrade J Jefferies
Hold → Buy $15 → $15.50 -3.3% Feb 06, 2024 Resumed K KeyBanc Capital Markets
Sector Weight Jun 26, 2023 Upgrade K KeyBanc Capital Markets
Sector Weight → Overweight $24 +49.7% Jan 23, 2023 Upgrade J JP Morgan
Underweight → Neutral $6 → $18 +12.3% Jan 11, 2023 Upgrade W
Peer Perform → Outperform $25 +56.0% Jan 11, 2023 Upgrade B Barclays
Underweight → Overweight $6 → $22 +37.2% Nov 15, 2022 Downgrade B Barclays
Equal Weight → Underweight $6 -62.6% Oct 05, 2022 Downgrade C Citigroup
Buy → Neutral $25 → $9 -43.9% Sep 26, 2022 Downgrade K KeyBanc Capital Markets
Overweight → Sector Weight Sep 21, 2022 Downgrade J JP Morgan
Overweight → Underweight $26 → $9 -43.9%
Today 12:50PM
(Earnings Whispers)
-9.64%
07:00AM
Oct-26-26 06:05PM
Oct-21-26 07:00AM
Aug-06-26 07:00AM
09:22AM
Loading…
Aug-05-26 09:22AM
Jul-23-26 07:00AM
Jun-05-26 09:36AM
May-11-26 04:33PM
May-05-26 07:03AM
07:00AM
May-04-26 09:19AM
Apr-21-26 07:46AM
Mar-16-26 07:00AM
Mar-04-26 04:51PM
09:35AM
Loading…
Mar-03-26 09:35AM
Feb-24-26 04:00PM
12:49PM
09:30AM
08:50AM
07:28AM
07:00AM
Feb-23-26 07:19AM
Feb-22-26 10:07PM
Feb-17-26 07:30AM
Feb-05-26 07:30AM
Jan-18-26 11:04PM
Jan-14-26 11:34PM
Jan-12-26 07:00AM
Jan-07-26 07:30AM
03:11PM
Loading…
Dec-30-25 03:11PM
(Investor's Business Daily)
Dec-23-25 10:36PM
Dec-22-25 11:32PM
Nov-25-25 09:15AM
Nov-06-25 04:37PM
Nov-04-25 04:12PM
09:30AM
08:45AM
07:20AM
07:00AM
Nov-03-25 07:25AM
Nov-02-25 10:02PM
Oct-30-25 12:31AM
Oct-21-25 05:13PM
Oct-17-25 12:48AM
Sep-11-25 12:01AM
Sep-08-25 12:37AM
Sep-04-25 12:16PM
Sep-03-25 04:57PM
Aug-27-25 09:55AM
Aug-20-25 11:35PM
Aug-15-25 01:31AM
Aug-14-25 12:44AM
Aug-13-25 05:51PM
Aug-11-25 09:47AM
Aug-09-25 03:08AM
Aug-08-25 01:00PM
12:21PM
07:35AM
07:30AM
Aug-07-25 09:15AM
09:15AM
Aug-06-25 11:01PM
Aug-05-25 06:05PM
12:37AM
Jul-28-25 07:38AM
Jul-22-25 12:33AM
Jul-21-25 01:16PM
07:06AM
Jul-04-25 12:33AM
Jun-26-25 03:57AM
Jun-20-25 12:01AM
Jun-18-25 07:39AM
Jun-04-25 07:55AM
May-15-25 03:41PM
May-02-25 02:37PM
03:10AM
May-01-25 09:30AM
08:55AM
07:38AM
Apr-30-25 05:50PM
Apr-17-25 05:16PM
Apr-14-25 10:08AM
05:12AM
Apr-08-25 12:34PM
Mar-25-25 07:50AM
Mar-12-25 05:03AM
Mar-04-25 07:00AM
Feb-28-25 04:30AM
(Thomson Reuters StreetEvents)
02:22AM
Feb-27-25 03:45PM
09:30AM
08:40AM
07:15AM
07:00AM
Feb-26-25 08:13AM
07:19AM
Feb-24-25 09:16AM
Feb-18-25 04:30PM
Feb-17-25 08:44AM
Show Previous News
Insider Trading
Relationship
Date
Transaction
Cost
#Shares
Value ($)
#Shares Total
SEC Form 4
Petras Michael B. Jr. Executive Chairman Aug 17 '26 Sale 18.50 850,000 15,725,935 3,969,393 Aug 19 04:24 PM Petras Michael B. Jr. Executive Chairman Aug 17 '26 Sale 18.50 294,515 5,448,851 397,912 Aug 19 04:24 PM Michael B. Petras, Jr. Chairman, CEO Aug 17 '26 Proposed Sale 18.89 1,144,515 21,619,888 Aug 17 07:04 PM Rutz Michael P President of Sterigenics Aug 07 '26 Sale 18.84 150,000 2,825,250 334,279 Aug 11 04:24 PM Rutz Michael P Officer Aug 07 '26 Proposed Sale 18.91 150,000 2,836,500 Aug 07 09:27 AM WARBURG PINCUS & CO. Director May 13 '26 Sale 15.17 19,102,952 289,753,576 0 May 15 04:54 PM WARBURG PINCUS & CO. Director May 13 '26 Sale 15.17 19,102,952 289,753,576 0 May 15 04:48 PM GTCR INVESTMENT XI LLC Director May 13 '26 Sale 15.17 12,735,301 193,169,046 0 May 15 04:41 PM WARBURG PINCUS & CO. Director Mar 06 '26 Sale 15.27 15,000,000 229,050,000 19,102,952 Mar 10 07:50 PM WARBURG PINCUS & CO. Director Mar 06 '26 Sale 15.27 15,000,000 229,050,000 19,102,952 Mar 10 07:49 PM GTCR INVESTMENT XI LLC Director Mar 06 '26 Sale 15.27 10,000,000 152,700,000 12,735,301 Mar 10 06:10 PM Petras Michael B. Jr. Chairman & CEO Dec 08 '25 Sale 16.45 434,104 7,141,011 0 Dec 10 04:43 PM Petras Michael B. Jr. Chairman & CEO Dec 08 '25 Sale 16.45 315,896 5,196,489 552,790 Dec 10 04:43 PM Michael B. Petras, Jr. Chairman, CEO Dec 08 '25 Proposed Sale 16.75 750,000 12,562,500 Dec 08 05:11 PM WARBURG PINCUS & CO. Director Dec 03 '25 Sale 16.33 9,720,000 158,727,600 34,102,952 Dec 05 08:47 PM WARBURG PINCUS & CO. Director Dec 03 '25 Sale 16.33 9,720,000 158,727,600 34,102,952 Dec 05 08:43 PM GTCR INVESTMENT XI LLC Director Dec 03 '25 Sale 16.33 6,480,000 105,818,400 22,735,301 Dec 05 08:10 PM GTCR FUND XI/C LP Owner Dec 03 '25 Proposed Sale 16.33 1,295,747 21,159,549 Dec 04 06:01 AM GTCR CO-INVEST XI LP Owner Dec 03 '25 Proposed Sale 16.33 41,219 673,106 Dec 03 09:59 PM GTCR FUND XI/A LP Owner Dec 03 '25 Proposed Sale 16.33 5,143,033 83,985,729 Dec 03 09:59 PM WARBURG PINCUS LLC Affiliate Dec 03 '25 Proposed Sale 16.84 9,720,000 163,684,800 Dec 03 08:53 PM GTCR INVESTMENT XI LLC Director Nov 10 '25 Sale 15.65 12,000,000 187,812,000 29,215,301 Nov 12 05:06 PM WARBURG PINCUS & CO. Director Nov 10 '25 Sale 15.65 18,000,000 281,718,000 43,822,952 Nov 12 04:18 PM WARBURG PINCUS & CO. Director Nov 10 '25 Sale 15.65 18,000,000 281,718,000 43,822,952 Nov 12 04:11 PM
Sotera Health Co. provides mission-critical sterilization, lab testing and advisory services to the medical device and pharmaceutical industries. It also provides end-to-end sterilization as well as microbiological and analytical lab testing and advisory services to help ensure that medical, pharmaceutical and food products are safe for healthcare practitioners, patients and consumers. The firm operates through the following businesses: Sterigenics, Nordion, and Nelson Labs. The Sterigenics business provides outsourced terminal sterilization and irradiation services for the medical device, pharmaceutical, food safety and advanced applications markets by using following technologies: gamma irradiation, EO processing and E-beam irradiation. The Nordion business provides Co-60 and gamma irradiators, which are the key components to the gamma sterilization process. The Nelson Labs business provides outsourced microbiological and analytical chemistry testing and advisory services for the medical device and pharmaceutical industries. The company was founded in 1978 and is headquartered in Broadview Heights, OH.
Executive Chairman of the Board Mr. Michael B. Petras Jr.
Senior VP & CFO Mr. Jonathan M. Lyons
President of Sterigenics U.S. Mr. Michael P. Rutz
CEO & Director Mr. Alton E. Shader
Chief Information Officer Mr. Robert G. Hauzie
S